Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan for prevention of severe COVID-19 outcomes in hospitalized adults
NL-OMON49095Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Valsartan with Placebo (2 arms). Primary endpoint: Composite of ICU admission, mechanical ventilation, or death within 14 days. Started Apr 2020; status: active, not recruiting.
02
Drugs
valsartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON49095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49095.